| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/10/2008 | US20080008766 Methods of Repairing Bone |
| 01/10/2008 | US20080008765 Taste-Masking Pharmaceutical Compositions |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | US20080008763 Composition and methods for the enterosorption and management of toxins |
| 01/10/2008 | US20080008761 Pharmaceutical Formulation Administrable Orally In Terms Of A Taste, Consistency And A Dosing |
| 01/10/2008 | US20080008759 Method of improving wound healing |
| 01/10/2008 | US20080008758 Granulate-matrix |
| 01/10/2008 | US20080008756 Homogenous Solid Matrix Containing Vegetable Protein |
| 01/10/2008 | US20080008755 Pharmaceutical formulation of cholanic acid-chitosan complex incorporated with hydrophobic anticancer drugs and preparation method thereof |
| 01/10/2008 | US20080008754 Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol |
| 01/10/2008 | US20080008753 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 01/10/2008 | US20080008752 Pharmaceutical compositions of memantine |
| 01/10/2008 | US20080008751 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 01/10/2008 | US20080008750 Band-Seals For Hard Capsules |
| 01/10/2008 | US20080008749 Ceramide composition and method of use |
| 01/10/2008 | US20080008748 Method for treating pain using a substituted 2-aminotetralin compound |
| 01/10/2008 | US20080008747 Transdermal patch |
| 01/10/2008 | US20080008746 Compositions and method for treatment of Attention Deficit Disorder and Attention Deficit/Hyperactivity Disorder with methylphenidate |
| 01/10/2008 | US20080008745 Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedles |
| 01/10/2008 | US20080008743 Orally Dissolving Formulations of Memantine |
| 01/10/2008 | US20080008742 Chewy products and methods for making the same |
| 01/10/2008 | US20080008740 Pharmaceutical Composition for Rectal, or Vaginal Application, Method of Manufacturing and Use as Medicament Thereof |
| 01/10/2008 | US20080008733 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 01/10/2008 | US20080008727 Compositions comprising adapalene dissolved with cyclodextrins |
| 01/10/2008 | US20080008689 Method for Transdifferentiation of Non Pancreatic Stem Cells to the Pancreatic Differentiation Pathway |
| 01/10/2008 | US20080008664 Method of reducing infection |
| 01/10/2008 | US20080008663 Method of reducing inflammation |
| 01/10/2008 | US20080008662 Aerosol Drug Inhibition of Lung Cancer |
| 01/10/2008 | US20080008661 Methods and compositions for treating erectile dysfunction |
| 01/10/2008 | US20080008647 Biodegradable polymer particles |
| 01/10/2008 | US20080006115 Shifter with actuator incorporating magnetic unlock mechanism |
| 01/10/2008 | US20080006112 Shifter with actuator incorporating shape memory alloy |
| 01/10/2008 | DE19528029B4 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use |
| 01/10/2008 | DE102006031758A1 Composition, useful e.g. for the reduction of the penetration of body fluids into urethra, comprises at least two different hydrophobic compound such as vegetable oil, where the composition lock the urethra over the cross-section |
| 01/10/2008 | DE102006030166A1 Tempern Temper |
| 01/10/2008 | DE102005025057B4 Verfahren zum Herstellen von Nanopartikeln unter Verwendung poröser Membranen A method of producing nanoparticles using porous membranes |
| 01/10/2008 | DE10015463B4 Creme in Form einer überwässerten Wasser-in-Öl-Emulsion Cream in the form of a überwässerten water-in-oil emulsion |
| 01/10/2008 | CA2656903A1 An oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof |
| 01/10/2008 | CA2656540A1 Ibuprofen-containing liquid filled hard capsules |
| 01/10/2008 | CA2656489A1 Hydrophilic polyurethane compositions |
| 01/10/2008 | CA2656395A1 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 01/10/2008 | CA2656332A1 Metal-containing formulations and methods of use |
| 01/10/2008 | CA2656318A1 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 01/10/2008 | CA2656270A1 Solid dose formulations of a thrombin receptor antagonist |
| 01/10/2008 | CA2656131A1 Pharmaceutical composition containing a tetrahydrofolic acid |
| 01/10/2008 | CA2656087A1 Sugar-free storage-stable antihistaminic syrups |
| 01/10/2008 | CA2655164A1 Delivery device having self-assembling dendritic polymers and method of use thereof |
| 01/10/2008 | CA2654902A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/10/2008 | CA2654529A1 Compositions with controlled pharmacokinetics |
| 01/10/2008 | CA2654525A1 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
| 01/10/2008 | CA2654523A1 Pharmaceutical compositions of memantine |
| 01/10/2008 | CA2654383A1 Pharmaceutical compositions of ropinirole and methods of use thereof |
| 01/09/2008 | EP1876175A1 Therapeutic agent for corneal disease |
| 01/09/2008 | EP1875926A1 Stable emulsion composition |
| 01/09/2008 | EP1875918A2 New use of ammonium chloride for the therapy of total or partial hepatic failure and necrosis |
| 01/09/2008 | EP1875917A2 Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction |
| 01/09/2008 | EP1875914A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/09/2008 | EP1875913A1 Compositions and method for treating infection in cattle and swine |
| 01/09/2008 | EP1875911A1 Stabilized composition |
| 01/09/2008 | EP1875910A1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine |
| 01/09/2008 | EP1875909A2 Use of antagonists of PYY receptors for treating irritable bowel syndrome |
| 01/09/2008 | EP1875905A2 Pharmaceutical compound in the form of a hydrogel for transdermal application of active substances |
| 01/09/2008 | EP1875901A1 Propofol-containing fat emulsion |
| 01/09/2008 | EP1875898A2 Transdermal patch for administering fentanyl |
| 01/09/2008 | EP1875897A1 Preparations for reviving, stimulating and enhancing hair growth |
| 01/09/2008 | EP1875896A1 Solubilisation formulation |
| 01/09/2008 | EP1875816A2 Beverages with specialized supplements |
| 01/09/2008 | EP1875560A2 Diffusion delivery systems and methods of fabrication |
| 01/09/2008 | EP1874726A2 Organic compounds |
| 01/09/2008 | EP1874456A1 New type of phase separation of micellar colloid solutions |
| 01/09/2008 | EP1874389A1 A system for transmembrane administration of a permeant |
| 01/09/2008 | EP1874357A1 Pharmaceutical dosage forms comprising a lipid phase |
| 01/09/2008 | EP1874324A1 Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes |
| 01/09/2008 | EP1874314A2 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 01/09/2008 | EP1874291A2 Novel use of zinc gluconate for treating hydradenitis suppurativa |
| 01/09/2008 | EP1874284A2 Eutectic blends containing a water soluble vitamin derivative |
| 01/09/2008 | EP1874282A2 Methods and compositions for treatment of cns disorders |
| 01/09/2008 | EP1874279A2 Water-soluble films comprising nicotine |
| 01/09/2008 | EP1874278A2 Compositions containing micronized tanaproget |
| 01/09/2008 | EP1874277A1 Sustained release l-arginine formulations and methods of manufacture and use |
| 01/09/2008 | EP1874276A2 Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability |
| 01/09/2008 | EP1874275A1 Compositons and methods for stabilizing active pharmaceutical ingredients |
| 01/09/2008 | EP1874274A2 Matrix-based pulse release pharmaceutical formulation |
| 01/09/2008 | EP1874273A2 Gastroresistant pharmaceutical formulations containing rifaximin |
| 01/09/2008 | EP1874272A2 Nanoparticulate and controlled release compositions comprising prostaglandin derivatives |
| 01/09/2008 | EP1874271A1 Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer |
| 01/09/2008 | EP1874270A2 Pharmaceutical aerosol composition |
| 01/09/2008 | EP1874269A2 Combination of tramadol and substances that comprise gabapentin |
| 01/09/2008 | EP1874268A1 Injectable depot formulations and methods for providing sustained release of nanoparticle compositions |
| 01/09/2008 | EP1874267A1 Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles |
| 01/09/2008 | EP1784170B1 Atrium patch |
| 01/09/2008 | EP1781252B1 Method for producing coated drugs having a stable profile for the release of active ingredients |
| 01/09/2008 | EP1682146B1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 01/09/2008 | EP1446118B1 Oral dosage form of parecoxib |
| 01/09/2008 | EP1399531B1 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 01/09/2008 | EP1385487B1 Tablets with coloured patterns and preparation thereof |
| 01/09/2008 | EP1377183B1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
| 01/09/2008 | EP1283043B1 Ophthalmic solution |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | EP1044009B1 Methods and compositions employing red rice fermentation products |